Project
A phase III trial evaluating the role of ovarian function suppression and the role of exemestane as adjuvant therapies for premenopausal women with endocrine responsive breast cancer (STP)
Ongoing - recruitment closed · 2009 until 2099
Huober Jens, Demmer-Steingruber Ruth, Quinter Janine
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2009
End Date
2099
Financing
Industry
Labels
breast cancer